Iovance Biotherapeutics (IOVA) Cash & Current Investments (2010 - 2026)
Iovance Biotherapeutics (IOVA) recorded Cash & Current Investments of $297.71 million in Q2 2026, down 1.2% from $301.18 million a year earlier and down 5.0% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Iovance Biotherapeutics reported Cash & Current Investments of $296.98 million, down 8.3% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $323.78 million in FY2024 (+15.7%), $279.87 million in FY2023 (-40.7%), $471.85 million in FY2022 (-6.5%) and $504.41 million in FY2021 (-20.6%).
- Quarterly Cash & Current Investments has ranged from $164.19 million in Q3 2024 to $626.29 million in Q1 2023 over the past five years.
- On a year-over-year basis, Cash & Current Investments has declined for three consecutive quarters, with growth averaging 6.8% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 83.2% in Q3 2025, against a decline of 54.6% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $313.44 million (Q1 2026), $296.98 million (Q4 2025) and $300.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.76 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 7.14 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.92 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 4.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 11.70 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.85 Bn |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn | 297.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 297.71 Mn |
| Mar 31, 2026 | 313.44 Mn |
| Dec 31, 2025 | 296.98 Mn |
| Sep 30, 2025 | 300.83 Mn |
| Jun 30, 2025 | 301.18 Mn |
| Mar 31, 2025 | 359.71 Mn |
| Dec 31, 2024 | 323.78 Mn |
| Sep 30, 2024 | 164.19 Mn |
| Jun 30, 2024 | 228.68 Mn |
| Mar 31, 2024 | 356.20 Mn |
| Dec 31, 2023 | 279.87 Mn |
| Sep 30, 2023 | 361.42 Mn |
| Jun 30, 2023 | 250.91 Mn |
| Mar 31, 2023 | 626.29 Mn |
| Dec 31, 2022 | 471.85 Mn |
| Sep 30, 2022 | 360.17 Mn |
| Jun 30, 2022 | 424.48 Mn |
| Mar 31, 2022 | 482.19 Mn |
| Dec 31, 2021 | 504.41 Mn |
| Sep 30, 2021 | 576.49 Mn |
API Access
Iovance Biotherapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();